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ABSTRACT 
 
 MicroRNAs are short regulatory RNAs that primarily operate at the post-
transcriptional level, acting as part of the RISC complex to destabilize mRNA prior to, 
or during, translation. MicroRNAs are subject to several levels of processing by Drosha 
and Dicer prior to achievement of the active mature form, this processing being highly 
dependent on the secondary structure of the microRNA transcript. As such, microRNA 
biogenesis is highly sensitive to mutations. In this study, it was attempted to optimize 
Cas9-mediated genome editing techniques for microRNA knockout for two 
hematopoietic microRNAs, miR-142 and miR-223. 
 While it has been previously demonstrated that Cas9 is capable of inhibiting 
microRNA biogenesis, the results have been characterized by variable and low-level 
efficiencies currently inherent to the system. This study attempted to rectify this 
shortcoming by bombarding the small pre-miR transcript with a combination of multiple 
independently targeted Cas9 complexes, using lentiviral delivery methods, measuring for 
evidence of impaired microRNA biogenesis by real-time quantitative PCR (RT-qPCR). 
The results suggest that there may be specific regions of the microRNA site in which 
mutations are more deleterious to function, but that further study is required. 
Additionally, it was determined that the use of multiple sgRNAs is not experimentally 
useful, proving unable to and in some cases, an impediment to successful microRNA 
knockout. 
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1. INTRODUCTION 
 
MicroRNAs are a class of short (20-22 bases) non-coding regulatory RNAs 
believed to act primarily at the post-transcriptional level, functioning as the target-
specifying element of the RNA Induced Silencing Complex (RISC) [1]. MiRNA 
biogenesis is a multi-step process, heavily reliant on the secondary structure of the 
maturing RNA for proper recognition and processing [2, 3]. The primary miRNA (pri-
miR) is transcribed as an oligonucleotide of variable length containing one or more 
precursor miRNAs (pre-miR) as bulged hairpin structures [4]. Each pre-miR is cleaved 
from the pri-miR at a highly defined point 11 bp from the 5’ base of the stem, and the 
65-100 base pre-miR is exported from the nucleus, where it is recognized and processed 
by Dicer [5]. Dicer activity leaves a 20-22 bp dsRNA molecule which is loaded into the 
RISC complex with one strand being the retained guide strand, and the other being the 
ejected (and presumably degraded) passenger strand [6]. The RISC-associated guide 
miRNA then assumes its main function as a post-transcriptional regulatory element [7], 
binding to and destabilizing mRNAs that contain 3’ UTR sites partially complementary 
to the RISC guide RNA [8, 9]. This partial complementarity is characterized by a 6-8 bp 
5’ “seed” region, a short non-complementary bulge, and a second region of 
complementarity stretching the remainder of the miRNA [10, 11]. 
MiRNA function is reliant on the primary sequence, both for accurate targeting 
of the RISC complex, and the biogenesis of the miRNA [12]. Both Drosha and Dicer 
recognize their respective miRNA substrates by the primary sequence-dependent 
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secondary structures [11, 13]. Additionally, each pre-miRNA contains the guide and 
passenger strand sections, disruption of which could lead to aberrant selection and 
loading into the RISC complex, or mistargeting of the RISC complex by mutations 
within the guide sequence [10]. Such mutations may render the RISC unable to bind the 
normal mRNA target UTR sites, direct it to other mRNAs, or convert the miRNA into a 
siRNA (which acts to cleave,rather than destabilize an mRNA) by enabling complete 
complementarity between the guide strand and the mRNA.  
Cas9 is the nucleolytic component of the type II CRISPR (Clustered Regularly 
Interspaced Short Palindromic Repeat) system [14], and composed of the Cas9 nuclease, 
a variable-sequence 18-22 base ssRNA guide oligo (sgRNA) that defines the target 
dsDNA, and a 70-100 base ssRNA tracrRNA, which acts as a scaffold for the nuclease 
[15, 16]. This system has rapidly become the primary means of editing DNA, primarily 
due to the ease with which the complex can be re-targeted, requiring only the design of a 
new sgRNA [17]. The set of sequences that can be targeted by the Cas9 system is 
determined by the protospacer-adjacent motif (PAM), a short sequence on the DNA 
recognized by the protein component, and varying by species [18, 19]. spCas9, the most 
common complex used, recognizes the ‘NGG’ PAM, granting an extremely permissive 
spread in sgRNA design [20]. Both PAM recognition and base pairing between the 
sgRNA and DNA are required for Cas9 nucleolytic activity [21], generating a blunt 
double-stranded break in the target DNA molecule. Binding does not necessitate 
nuclease activity [22], and the complex exhibits high affinity for its target [23], a feature 
that can be exploited by using nuclease-deficient variants of Cas9 as transcriptional 
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inhibitors [24], or as the targeting component for other effectors fused to the complex 
[25]. Once a double-stranded break has been induced, it may be repaired by one of 
several cellular DNA damage pathways, the two primary methods being homology-
directed repair (HDR) [26] and non-homologous end-joining (NHEJ) [27]. While HDR 
yields a faithful repair, it requires the availability of a homologous allele, and as such is 
only active during the G2 and S phases [28]. NHEJ is the primary repair pathway, active 
throughout all cell cycles [29, 30]. However, NHEJ is error-prone, typically generating 
small insertions or deletions (in/dels) at the repair site [31, 32].  
It has already been demonstrated that a single sgRNA/Cas9 complex can lower 
the expression of a miRNA[33], and that even single-base alterations at the 5’ Drosha 
processing site can completely abrogate miRNA biogenesis [34]. However, it is not 
known whether this is a property active during Drosha recognition, applicable to all 
processing steps, or whether in/dels in other locations may be equally efficacious. 
Additionally, the Cas9 complex shares the drawbacks of more traditional DNA editing 
systems (TALENs and zinc-finger nucleases), exhibiting a variable lack of both 
specificity and nuclease activity [35, 36]. Cas9 systems require high expression for 
acceptable levels of editing [23], which in turn leads to increases in off-target editing 
[25]. Furthermore, there is significant variability between different sgRNA sequences 
[17], not ascribable to chromatin or methylation status [37]. While chemically modified 
sg/tracrRNA oligos possessing 5’ and 3’ protective add-ons have been recently show to 
greatly improve Cas9 activity and consistency [38], these options are not available for 
many of the current delivery methods (virions, protein/DNA nanocages, naked DNA 
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delivery, etc.) [39-41], which require transcription by the target cell. Given the 
attractiveness of Cas9-based systems for genome editing, the highly variable and overall 
low efficiency of Cas9 is an obstacle in the path of gene therapy research, particularly in 
such areas as hematopoietic stem cell editing, in which high efficiency is paramount for 
effective transfusions [42, 43]. In the context of protein-coding genes, these difficulties 
may be overcome through the use of several sgRNAs, spaced over the available 
kilobases of gene [44]. However, the short stretch of a pre-miR sequence does not permit 
luxurious spacing with a multiplex approach. The interaction of multiple co-occurring 
Cas9 complexes in close proximity has not been specifically investigated, except for 
indirect observations gleaned from the use of a dual FokI-dCas9 fusion system (capable 
of reducing off-target editing at the cost of efficiency) [17, 45]. However, in that case, it 
is not known if the reduced efficiency of the two-sgRNA system is a result of complex 
proximity, or the altered protein, or lowered overall expression.  
Accordingly, the intent of this study was to investigate the use of Cas9 to induce 
loss of function in two hematopoietic but functionally unrelated miRNAs, miR-142 [46] 
and miR-223 [47], with two specific aims. First, to determine if it is either necessary or 
beneficial to confine Cas9-generated in/dels to particular regions of the pre-miRNA 
secondary structure. The alternative hypothesis would be that any mutation is capable of 
causing loss of function, either by disruption of biogenesis or by altering the binding 
sequence of the assembled RISC. Second, to determine whether the low efficiencies of 
individual sgRNAs can act additively when multiple sgRNAs are co-delivered, or if the 
short sequence length proves an impediment to such brute force approaches. 
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2. METHODS 
 
2.1 Construct Design 
pSpCas9(BB)-2A-GFP (pX458, Addgene plasmid #48138) and lentiCRISPRv2 
(Addgene plasmid #52961) were gifts from Feng Zhang, through Addgene. pSICHECK 
was obtained from Promega. All sgRNA oligos were designed using CRISPR Design 
Tool (http://crispr.mit.edu), and ordered from IDT. As both spCas9 constructs express 
the tracrRNA component as a single oligo with the inserted sgRNA oligo, design of the 
tracrRNA was not necessary. All seventeen guides were cloned into both the pX458 and 
lentiCRISPRv2 plasmids using Mix & Go 5α chemically competent cells (Zymo), and 
insertion verified by end-point PCR, restriction enzyme digestion, and sequencing. Pre-
miR-142b (comprising the true pre-miR-142 and the extended Drosha recognition 
region) was PCR amplified from murine (C57BL/6) gDNA, and cloned into the MCS of 
pSICHECK2 using the same method as above. All PCR primers used throughout this 
study were designed using NCBI PrimerBLAST. 
2.2 pX458 and pSICHECK2 Transfection 
 HEK293T cells were grown in IMDM (Hyclone) supplemented with 10% fetal 
bovine serum, at 37°C and 5% CO2, and grown to ~70% confluency in 6-well plates. 
The pX458 contructs and pSICHECK constructs were transfected at a 1.5/1 molar ratio 
in 96-well plates using X-tremeGENE HP DNA transfection reagent (Roche) according 
to the manufacturer’s protocols. The transfection reagent was removed after six hours, 
and the luciferase data obtained at forty-eight hours using the Dual-Glo Luciferase 
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Assay System (Promega), according to the manufacturer’s protocols. To collect gDNA 
for analysis of spCas9 nuclease activity, the pX458 constructs were transfected into 
HEK293T cells in the same manner as before, and the DNA collected using the 
GenElute Mammalian Genomic DNA Miniprep kit (Sigma-Aldrich). The ~300 bp 
surrounding the pre-miR-142 region was PCR amplified, and the product purified by 
agarose gel extraction. Sequencing data was analyzed with the web-based TIDE tool 
(http://tide.nki.nl). 
2.3 Lentiviral Transduction 
 Lentiviral transduction virions were generated using HEK293T cells, transfected 
in the same manner as before (quantities adjusted to 2.5 µg total DNA/well in 6-well 
plates), using the seventeen lentiCRISPRv2 constructs (ten targeting miR-142, seven 
targeting miR-223), the psPAX2 packaging plasmid (a gift from Didler Trono, Addgene 
plasmid #12260), and a VSV-G expression construct, at an equimolar ratio. The 
transfection reagent was removed after six hours, and the virion-containing media 
collected at forty-eight and seventy-two hours, having been stored at 4°C. The two 
collection fractions were combined, brought to 0.4M NaCl and 8.5% w/v PEG6000, and 
rotated for ninety minutes at 4°C. The pegylated virions were then centrifuged at 10,000 
rcf for fifteen minutes, and the viral pellet re-suspended at a 30X concentration. The 
concentrated virus was then transduced into EML and RAW 264.7 cells, as appropriate.  
 EML cells were grown in IMDM (Hyclone) supplemented with 20% fetal bovine 
serum and 15% BHK/MKL-conditioned media, at 37°C and 5% CO2. RAW264.7 cells 
were grown in IMDM (Hyclone) supplemented with 10% fetal bovine serum, at 37°C 
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and 5% CO2. For both cell types, 50,000 cells were transduced at an approximate MOI 
of ten, in the presence of 6 µg/mL polybrene, and centrifuged at 800 rcf for 75 minutes 
at 30°C immediately after introduction of the virion-containing media. The media was 
replaced after twelve hours, and total RNA collected after forty-eight hours using the 
RiboZol RNA Extraction Reagent (Amresco) and the Direct-Zol RNA Miniprep Kit 
(Zymo). MOI was measured by titration of the viral concentrate into HEK293T cells, 
and selecting for infection events by 2 µg/mL puromycin. 
2.4 RT-qPCR miRNA Detection and Data Analysis 
From the total RNA extraction, cDNA was generated using the Universal cDNA 
Synthesis Kit (Exiqon), and subjected to RT-qPCR using the iTaq Universal Sybr Green 
One-Step Kit (Bio-Rad) and the appropriate Exiqon LNA miRNA primers. Output was 
collected on Bio-Rad CFX Manager, and analyzed with Prism 6.0a by one-way ANOVA 
or unpaired t-tests, as appropriate. Normalization was conducted using primers against 
miR-103a, and the Exiqon UniSp6 spike-in control. Significance values reported are for 
multiple comparison t-tests vs. the experimental control values. 
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3. RESULTS 
 
3.1 In Vitro Plasmid Disruption 
 In order to determine the variability of efficiency for the available suite of 
sgRNAs, 10 sgRNAs for mmu-pre-miR-142 were designed and cloned into the pX458 
transfection plasmid, expressing spCas9-eGFP and a fused sgRNA/tracrRNA construct 
driven by the U6 promoter (demonstrated to be indistinguishable in function from a 
wild-type two-oligonucleotide system) (Figure 1). Additionally, the mmu-pre-miR-142 
sequence was PCR amplified from C57BL/6 mice, and inserted into the multiple cloning 
site of the pSICHECK2 plasmid, downstream of a renilla luciferase reporter, and 
upstream of a synthetic poly-A tail. As diagramed in Figure 1A, the actual miRNA 
sequence used was larger than the strictly defined pre-miRNA, extending into the 
Drosha binding and recognition region of the pri-miRNA, but will be referred to as the 
pre-miRNA-142 for convenience. Since Cas9 can inhibit transcription by tightly binding 
substrate DNA, it was hypothesized that the relative effectiveness of the Cas9 sgRNAs 
could be determined by observing decreased levels of luciferase expression, via either 
disruption of transcription, or degradation of the plasmid by exposure to exonucleases. 
The pX458-sgRNA plasmids was co-transfected with the pSICHECK-pre-miR142 
plasmid into HEK293T cells, and luciferase expression assayed after 48 hours. 
Uniformly, the presence of Cas9 and an sgRNA reduced luciferase expression to 
between 40% to 63% of the no-sgRNA control (Figure 2A). While this limited 
variability was not remarkable, given that the effects did not rely on the specific location 
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of binding, it demonstrated that there was a degree of heterogeneity in binding/cleaving 
efficiency. Interestingly, the addition of the pre-miR-142 sequence to the pSICHECK2 
3’ UTR consistently increased luciferase expression by an average of 50.6% in the 
absence of a targeting sgRNA (Figure 2B). 
 
A                        B 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Design of sgRNAs and pSICHECK system. (A) Positioning of Cas9 cut sites 
across the secondary structure of the pre-miR-142 and Drosha recognition region. 
Arrows indicate the specific sites of potential mismatch in the event of double-stranded 
break mutation. (B) Design of the pSICHECK2-pre-miR-142 construct, with the mmu-
pre-miR-142 inserted between the hRluc reporter and the synthetic poly-A tail. Base 
figure provided by Promega. 
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sgRNA Sequence Cut position 
miR-142 sg01 AGTAGTGCTTTCTACTTTAT 30 
miR-142 sg02 TAGTAGTGCTTTCTACTTTA 32 
miR-142 sg03 GAAAGCACTACTAACAGCAC 53 
miR-142 sg04 AGCACTACTAACAGCACTGG 56 
miR-142 sg05 GCACTACTAACAGCACTGGA 57 
miR-142 sg06 AGTGCACTCATCCATAAAGT 79 
miR-142 sg07 GTGTAGTGTTTCCTACTTTA 79 
miR-142 sg08 CTTTATGGATGAGTGCACTG 94 
miR-142 sg09 TTTATGGATGAGTGCACTGT 95 
miR-142 sg10 GATGAGTGCACTGTGGGCTT 101 
miR-223 sg01 ACGGAGCGTGACACTGCAGA 10 
miR-223 sg02 GTGTATTTGACAAGCTGAGT 45 
miR-223 sg03 GCTGAGTTGGACACTCTGTG 58 
miR-223 sg04 ATAGGCATGAGCCACACTTG 90 
miR-223 sg05 TGATAGGCATGAGCCACACT 92 
miR-223 sg06 TTTGTCAAATACCCCAAGTG 92 
miR-223 sg07 GATAGGCATGAGCCACACTT 91 
 
Table 1: sgRNA sequences. Complete set of 20-base sgRNA sequences as generated by 
CRISPR Design Tool, with the nucleolytic site location on the relevant pre-miR, 
counting 5’ to 3’. In the cases in which two sgRNAs are marked as possessing different 
sequences, but the same cleave point, this is an indicator of the two sgRNAs binding 
opposite strands of the target DNA, and happening to overlap exactly on the site of 
nuclease activity. 
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A                      B  
 
Figure 2: Cas9-induced Renilla luciferase down-regulation. (A) Relative Renilla 
luciferase expression in HEK293T cells 48 hours post-transfection (pX458 with a single 
sgRNA, or no-sgRNA control, and pre-miR-142-pSICHECK2), normalized against 
firefly luciferase expression. Error bars displayed indicate mean and SEM for three 
replicates. (B) Note the reduced expression of the unaltered pSICHECK2 vs. the pre-
miR-142-pSICHECK2. ★★★ = p ≤ 0.001; ★★★★ = p	 ≤ 0.0001, by one-way ANOVA and 
multiple comparison vs. control. 
 
 
3.2 DNA Damage Assessment 
 While assessment of Cas9 activity in down-regulating luciferase expression 
provided reassurance that the system was functional, it did not provide data on whether 
this was a result of nuclease activity, or merely bound but inactive complexes interfering 
with transcription. It was also a concern that Cas9 activity against a plasmid may not 
reflect activity against genomic DNA. Accordingly, the ten miR-142 guides were tested 
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by transfecting HEK293T cells with the sgRNA-Cas9 constructs, individually and in 
pairs, verifying consistent transfection efficiency by eGFP expression, and collecting 
genomic DNA after 48 hours. PCR primers were designed against the gDNA using 
NCBI PrimerBLAST to flank the pre-miR-142 sequence by approximately 300 bp up- 
and downstream, and used to both amplify the ~700 bp sequence from the gDNA, and 
sequence the amplified material. The resulting chromatographs were then analyzed via 
TIDE (Tracking of In/dels by DEcomposition), a DNA heterogeneity assessment tool 
designed and made available by the Bas van Steensel research group (Netherlands 
Cancer Institute) (Figure 3). Three items of note were observed. There was a lack of 
consistency between the luciferase experimental data and the frequency of actual gDNA 
mutation, the abrogation of mutation induced by a single base mismatch between the 
target and guide, and the differing effects of combining multiple guides. Although all 
constructs generated similar levels of luciferase inhibition, there was a wide difference 
between efficiencies when confronted by gDNA, ranging from 9.2% to 72.9%. A broad 
pattern was evident as to particular regions being more or less favorable for mutation, 
with the terminal loop being the most frequently mutated, and decreasing towards the 
Drosha cleavage point and beyond. This pointed towards the explanations that either 
anti-plasmid efficiency is drastically different from anti-gDNA efficiency, or else the 
dominant effect upon the pSICHECK2 system was steric transcription blockage. 
However, whether or not the pattern possesses any significance was still unknown, since 
HEK293T cells do not express miR-142, and thus gDNA lesion frequency could not be 
correlated with variation in expression of the mature miRNA within this system. Second, 
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single base mismatches between the sgRNA and the target (due to sequence 
inconsistencies between the human and murine miR-142) were sufficient to lower the 
nuclease activity by one to two orders of magnitude, as evidenced by sg08 (single 
mismatch 6 bases from PAM, 0.6% efficiency), and sg09 (single mismatch 5 bp from 
PAM, 3.0% efficiency). This result is entirely in accordance with the current 
understanding of Cas9 target binding and cleaving mechanics, which stipulate that 
mismatches far from the PAM may have little effect, but that there is a critical seed 
region. This region is generally defined as the 5-12 bases proximal to the PAM (the 
exact boundary is still a matter scientific dispute), which is essential for proper binding 
activity. Additionally, when co-transfected, neither mismatched complex was capable of 
rescuing an efficient degree of nucleolytic activity. Two other pairs of complexes were 
co-transfected, sg02/sg04 (separated by 25 bp) and sg03/sg05 (separated by 4 bp). 
Notably, the first pair (sg02/sg04) appeared to act additively, generating a combined 
in/del rate of 70.7%, compared to 21.7% and 38.1% respectively, when delivered 
individually. However, the spatially constricted (overlapping binding regions) sg03/sg05 
pair generated a mutation level of 15.7%, less than the level of either individual sgRNA 
(28.5% and 72.9%, respectively), indicative of the two complexes engaging in mutual 
inhibition. 
 
 
 
 
  14 
A         B  
 
C 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: HEK293T transfection and genomic DNA mutation assessment. (A) 
Representative image of eGFP expression for a HEK293T ~90% confluent well, 
transfected with sgRNA-pX458. (B) Mutation frequency for each sgRNA-pX458 and 
selected co-transfected pairs, as measured by TIDE by analysis of chromatograph base 
call certainty up and downstream (sequencing-wise) of a given predicted cut site. As the 
sgRNAs are labeled 5’ to 3’ by location on the pre-miR structure, a pattern can be 
observed, as mutation frequency builds from the Drosha cleavage site (sg01 and 02), 
comes to an apex at the terminal loop (sg05), and then drops again moving back down 
the stem. One the right side, the spatially overlapping 03/05 pair appear to inhibit each 
other, whereas the well separated 02/04 pair appear to function additively. (C) Plasmid 
map of the spCas9 expression sgRNA-pX458 construct. 
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3.3  miRNA Loss of Function Assessment 
 While HEK293T cells provide an environment for assessing the capabilities of 
the suite of sgRNAs to generate gDNA lesions, the lack of endogenous expression of 
either miR-142 or miR-223 render it impossible to verify that the damage has any effect 
on expression of mature, functional miRNA. Accordingly, for miR-142 expression, I 
turned to the EML cell line (a hematopoietic progenitor model), and for miR-223, to the 
RAW264.7 cell line (a macrophage model). Seven sgRNAs were designed for pre-miR-
223 as described for pre-miR-142. However, since both lines were not amenable to 
standard transfection methods, I used a replication-incompetent VSV-G lentivirus, 
carrying spCas9 and the sg/tracrRNA hybrid as in the previous experiments, and 
substituted puromycin resistance for eGFP. While it would have been desirable to use a 
non-integrating vector, integrase-deficient retroviruses are known for poorly expressing 
their payload (which is inimical to Cas9 activity). Adenoviruses are poor transducers of 
the hematopoietic stem cells intended to be represented by the EML line, and the size of 
the spCas9 and U6/sgRNA cassettes is prohibitive of smaller vectors. Thus, the lentiviral 
constructs were generated, used to form infectious virions in HEK293T cells according 
to standard viral generation protocols [48], and spin-transduced into the miRNA-
expressing target cells (all miR-142 sgRNAs into EML, all miR-223 sgRNAs into 
RAW264.7). After 48 hours (approximately 2.5 cell doublings, permitting sufficient 
time for the integrated spCas9 to afflict the miRNA locus), total RNA was collected and 
assayed for the mature miRNA by reverse-transcriptase quantitative PCR (RT-qPCR) 
(Figure 4, 5). sgRNAs were delivered singly, and also in sets of two and three. In 
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general, there was minimal enhancement from the use of more than one sgRNA per 
population, multiple sgRNAs acting either to inhibit the total loss of function effect in 
the case of miR-142-3p, or displaying no significant effect in the case of miR-223-3p. In 
fact, the combination of two poorly performing sgRNAs (sg03 and sg04) against miR-
223 appeared to increase miR-223-3p expression over that of the no-sgRNA control, and 
the pairing of the inefficient sg03 with more efficient sg07 completely rescued miR-223-
3p function. This was unexpected given that the two are separated by 32 bases, bind 
separate strands and are thus oriented away from each other. However, for both 
miRNAs, transduction of a single Cas9-sgRNA was sufficient to strongly and 
specifically reduce miRNA expression; no sgRNA construct significantly affecting the 
expression of the unrelated miR-103a (data not shown). Additionally, sgRNAs against 
miR-142 were unable to affect expression of miR-223, and vice versa. This was 
unsurprising, given that the two miRNAs are unrelated and located on different 
chromosomes (chr11 for miR-142, and chrX for miR-223). 
No statistically significant correlation was found between miRNA loss of 
function in EML cells (Figure 4) and the HEK293T DNA damage data (Figure 3B). It 
was noted that both of the sgRNAs containing a mismatch to human miR-142 performed 
well when targeting the murine EML gDNA, one in fact generating the best loss of 
function effect (sg08, with miR-142-3p expression reduced to 3.6% on average of the 
control level). Of the ten sgRNAs tested for miR-142, only one (sg06, targeting the 3p 
miRNA itself) was incapable of dropping miRNA expression below 50%. This could be 
interpreted as an artifact of the RT-qPCR detection method (picking up signal from 
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miRNAs not sufficiently mutated to prohibit amplification), or it may indicate that sites 
not directly interfacing with Drosha/Dicer machinery are poor choices if complete  
 
 
 
Figure 4: EML miR-142-3p expression for one sgRNA. Fig 4. Expression of miR-142-
3p in EML cells as measured by RT-qPCR 48 hours post-transduction. Error bars 
display mean and SEM, expression normalized to define relative expression as a 
percentage compared to the no-sgRNA control. All expression results for this figure are 
significant at p ≤ 0.0001 by one-way ANOVA and multiple comparison vs. control. 
Normalization was conducted using miR-103a and the Exiqon UniSp6 spike-in control. 
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Figure 5: RAW264.7 miR-223-3p expression for one sgRNA. Expression of miR-223-3p 
in RAW cells as measured by RT-qPCR 48 hours post-transduction. Error bars display 
mean and SEM, expression normalized to define relative expression as a percentage 
compared to the no-sgRNA control. ★ = p ≤ 0.05; ★★★ = p ≤ 0.001; ★★★★ = p	 ≤ 0.0001, 
by one-way ANOVA and multiple comparison vs. control. Normalization was conducted 
using miR-103a and the Exiqon UniSp6 spike-in control. 
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knockout is desired (as opposed to the generation of mistargeted or targetless miRNAs). 
However, sg07, which targets the exact same phosphodiester bonds but from the 
opposite orientation, reduces expression to 26.06% of the control, on par with the effects 
generated by most of the other sgRNAs. The seven sgRNAs against miR-223 
gave results comparable to the sgRNAs against miR-142; five lowered expression to less 
than 50% of the control (Figure 7). Interestingly, the two poor performers (sg03, sg04) 
are located in the same rough location as the best performer (sg05), clustered on the edge 
of the miR-223-3p element and trailing to the Drosha cut site. All data was obtained 
form whole populations, without selection for transduced cells.  
 For miR-142, in no case did the addition of a second or third sgRNA improve the 
loss of function effect (Figure 6). In fact, multiple sgRNAs not only inhibited each other, 
but in many cases, they acted to completely rescue miRNA expression, and/or increase it 
over that of the control population. This generally was not the case for the battery 
arrayed against miR-223, which did not exhibit such counter-intuitive mechanics, with 
the exception of sg03 and sg04, which increased miRNA expression over the baseline, 
and one case of functional rescue when combining sg03 and sg07 (Figure 7). However, 
the addition of more than one sgRNA per population did not significantly enhance the 
loss of function effect, and I concluded from these studies on miR-142 and miR-223, 
that it is not beneficial to stack multiple Cas9 complexes without sufficient space. A 
caveat to this conclusion is that all sgRNA combinations were administered at the same 
overall MOI (10 MOI, from viral preparations concentrated to approximately 1E6 
TU/mL, tittered via puromycin resistance [49]) 
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Figure 6: Effects of adding multiple anti-miR-142 sgRNAs to EML culture. Expression 
of miR-142-3p in EML cells 48 hours post-transduction. Single sgRNA-transduced 
populations are compared to paired (A), or three (B) sgRNAs. Error bars display mean 
and SEM, expression normalized to define relative expression as a percentage compared 
to the no-sgRNA control. ★ = p ≤ 0.05; ★★ = p ≤ 0.01; ★★★★ = p	 ≤ 0.0001, by one-way 
ANOVA and multiple comparison vs. control. Normalization was conducted using miR-
103a and the Exiqon UniSp6 spike-in control. 
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Figure 7: Effects of adding multiple anti-miR-223 sgRNAs to RAW264.7 culture. 
Expression of miR-223-3p in RAW cells 48 hours post-transduction. Single sgRNA-
transduced populations are compared to paired (A), or three (B) sgRNAs. Error bars 
display mean and SEM, expression normalized to define relative expression as a 
percentage compared to the no-sgRNA control. ★ = p ≤ 0.05; ★★ = p ≤ 0.01; ★★★ = p ≤ 
0.001; ★★★★ = p	 ≤ 0.0001, by one-way ANOVA and multiple comparison vs. control. 
Normalization was conducted using miR-103a and the Exiqon UniSp6 spike-in control. 
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4. CONCLUSIONS 
 
 In this study, I attempted to determine the ability of the Cas9 system in general to 
affect miRNA function and biogenesis, specifically using miR-142 and miR-223, and to 
also investigate the possibility of overcoming the inherent inefficiencies of Cas9 by 
employing several independently targeted complexes against the same general sequence. 
This study included assays on the ability of spCas9 to down-regulate a luciferase 
reporter, to induce gDNA lesions in HEK293T cells, and to knock out miRNA function 
in EML and RAW264.7 cell lines. The primary discovery was the broad utility of Cas9 
in miRNA knockout, the generation of mutation along any portion of the pre-miRNA or 
Drosha binding area being sufficient to effectively and specifically disrupt miRNA 
function. miRNA knockout can be accomplished by the introduction of a single-sgRNA 
Cas9 complex, without needing to target specific points on the pre-miRNA or to employ 
two complexes in the hope of deleting the sequence in between. For the seventeen 
sgRNAs used in this study, three failed to reduce miRNA expression <50%, and the 
sgRNAs gave variable results; however as long as several sgRNAs are screened, the 
process of developing new knockout models should be successful. With this comes the 
caveat that these sgRNAs must be screened in the final system, since neither the 
luciferase reporter assay nor the estimation of gDNA lesion efficiency proved to be an 
accurate predictor of miRNA knockdown. It was discovered that the addition of pre-
miR-142 is capable of significantly increasing the expression levels of the hRluc 
component of the pSICHECK system. The addition results in an approximate tripling of 
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the length of the 3’ UTR, a large portion being double stranded, which could possibly 
increase translational efficiency, simply generate a more stable mRNA isoform. 
 Interestingly, the addition of more than one Cas9 complex to a single system 
proved to be at best neutral, and more often detrimental to the desired effect. This might 
be a result of steric hindrance, however this interfering effect was observed even with 
complexes separated by 69 bases and binding opposite strands. In some cases, this 
interference resulted in miRNA expression being not only completely rescued, but 
somewhat increased, which is a counterintuitive finding. Given that all sgRNA 
combinations were administered at the same overall MOI as the single sgRNA systems 
(thus diluting the effective expression levels of each individual sgRNA with increasing 
numbers), one possible explanation is that no individual complex achieved a sufficient 
concentration to effectively edit its targeted site. One issue left unaddressed by this study 
was to determine which stage of processing specifically is inhibited by each targeting 
site, and whether or not accumulation of the substrate prior to the point of inhibition 
could be detected. Additionally, miRNAs are capable of generating both 3p and 5p 
products, dependent on which strand is selected as the guide and the passenger. For both 
of the miRNAs selected for this study, the 3p form is the dominant and only detectible 
form in the chosen cell type, and was thus the measure of miRNA expression. However, 
it would be interesting to determine whether the location of Cas9-indiced mutations can 
affect strand selection, in the event that the miRNA is processed up to the RISC-loading 
phase. Additionally, all miR expression data was obtained form whole populations, 
without selection for the transduced subpopulation. Given the high MOI used throughout 
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the course of the experiment (validated by titration), it can be assumed that the majority 
of the population was affected for each case. However, the effects observed may have 
been somewhat muted by the presence of a non-trivial number of non-transduced cells, 
and the generation of stable sgRNA-spCas9 lines for each sgRNA may have provided a 
more precise measurement of the true actions of the spCas9 complex. 
 In conclusion, I have demonstrated that the spCas9 complex is fully sufficient for 
effective miRNA knockout, using only a single sgRNA guide oligo, directed to any point 
along the pre-miRNA in question, with only tentative evidence to suggest certain 
locations as having any superior effect. I have further shown that there is no shortcut or 
viable proxy for measurement of this knockout effect, and that there is no evidence to 
suggest that attempts to overcome low efficiency levels by multiplexed saturation will be 
successful. 
 
 
 
 
 
 
 
 
 
 
  25 
REFERENCES 
 
 
1. Ha, M. and V.N. Kim, Regulation of microRNA biogenesis. Nat Rev Mol Cell 
Biol, 2014. 15(8): p. 509-524. 
 
2. Starega-Roslan, J., E. Koscianska, P. Kozlowski and W. Krzyzosiak, The role of 
the precursor structure in the biogenesis of microRNA. Cellular and Molecular 
Life Sciences, 2011. 68(17): p. 2859-2871. 
 
3. Tsutsumi, A., T. Kawamata, N. Izumi, H. Seitz and Y. Tomari, Recognition of 
the pre-miRNA structure by Drosophila Dicer-1. Nat Struct Mol Biol, 2011. 
18(10): p. 1153-1158. 
 
4. Lee, Y., M. Kim, J. Han, K.H. Yeom, S. Lee, et al., MicroRNA genes are 
transcribed by RNA polymerase II. The EMBO Journal, 2004. 23(20): p. 4051-
4060. 
 
5. Cullen, B.R., Transcription and Processing of Human microRNA Precursors. 
Molecular Cell, 2004. 16(6): p. 861-865. 
 
6. Davis, B. and A. Hata, Regulation of MicroRNA Biogenesis: A miRiad of 
mechanisms. Cell Communication and Signaling, 2009. 7(1): p. 18. 
 
7. Lewis, B.P., C.B. Burge and D.P. Bartel, Conserved Seed Pairing, Often Flanked 
by Adenosines, Indicates that Thousands of Human Genes are MicroRNA 
Targets. Cell, 2005. 120(1): p. 15-20. 
 
8. Griffiths-Jones, S., R.J. Grocock, S. van Dongen, A. Bateman and A.J. Enright, 
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids 
Research, 2006. 34(suppl 1): p. D140-D144. 
 
9. Gurtan, A.M., V. Lu, A. Bhutkar and P.A. Sharp, In vivo structure–function 
analysis of human Dicer reveals directional processing of precursor miRNAs. 
RNA, 2012. 18(6): p. 1116-1122. 
 
10. Hogg, D.R. and Lorna W. Harries, Human genetic variation and its effect on 
miRNA biogenesis, activity and function. Biochemical Society Transactions, 
2014. 42(4): p. 1184-1189. 
 
11. Long, D., R. Lee, P. Williams, C.Y. Chan, V. Ambros, et al., Potent effect of 
target structure on microRNA function. Nat Struct Mol Biol, 2007. 14(4): p. 287-
294. 
  26 
12. Kumar, M.S., J. Lu, K.L. Mercer, T.R. Golub and T. Jacks, Impaired microRNA 
processing enhances cellular transformation and tumorigenesis. Nat Genet, 
2007. 39(5): p. 673-677. 
 
13. Schwab, R., C. Speth, S. Laubinger and O. Voinnet, Enhanced microRNA 
accumulation through stemloop-adjacent introns. EMBO reports, 2013. 14(7): p. 
615-621. 
 
14. Jinek, M., K. Chylinski, I. Fonfara, M. Hauer, J.A. Doudna, et al., A 
Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial 
Immunity. Science, 2012. 337(6096): p. 816-821. 
 
15. Ran, F.A., P.D. Hsu, J. Wright, V. Agarwala, D.A. Scott, et al., Genome 
engineering using the CRISPR-Cas9 system. Nat. Protocols, 2013. 8(11): p. 
2281-2308. 
 
16. Wang, H., H. Yang, Chikdu S. Shivalila, Meelad M. Dawlaty, Albert W. Cheng, 
et al., One-Step Generation of Mice Carrying Mutations in Multiple Genes by 
CRISPR/Cas-Mediated Genome Engineering. Cell, 2013. 153(4): p. 910-918. 
 
17. Hsu, Patrick D., Eric S. Lander and F. Zhang, Development and Applications of 
CRISPR-Cas9 for Genome Engineering. Cell, 2014. 157(6): p. 1262-1278. 
 
18. Anders, C., O. Niewoehner, A. Duerst and M. Jinek, Structural basis of PAM-
dependent target DNA recognition by the Cas9 endonuclease. Nature, 2014. 
513(7519): p. 569-573. 
 
19. Xu, K., C. Ren, Z. Liu, T. Zhang, T. Zhang, et al., Efficient genome engineering 
in eukaryotes using Cas9 from Streptococcus thermophilus. Cellular and 
Molecular Life Sciences, 2015. 72(2): p. 383-399. 
 
20. Hsu, P.D., D.A. Scott, J.A. Weinstein, F.A. Ran, S. Konermann, et al., DNA 
targeting specificity of RNA-guided Cas9 nucleases. Nat Biotech, 2013. 31(9): p. 
827-832. 
 
21. Pattanayak, V., S. Lin, J.P. Guilinger, E. Ma, J.A. Doudna, et al., High-
throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 
nuclease specificity. Nat Biotech, 2013. 31(9): p. 839-843. 
 
22. Mali, P., J. Aach, P.B. Stranges, K.M. Esvelt, M. Moosburner, et al., CAS9 
transcriptional activators for target specificity screening and paired nickases for 
cooperative genome engineering. Nat Biotech, 2013. 31(9): p. 833-838. 
  27 
23. Sternberg, S.H., S. Redding, M. Jinek, E.C. Greene and J.A. Doudna, DNA 
interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 2014. 
507(7490): p. 62-67. 
 
24. Larson, M.H., L.A. Gilbert, X. Wang, W.A. Lim, J.S. Weissman, et al., CRISPR 
interference (CRISPRi) for sequence-specific control of gene expression. Nat. 
Protocols, 2013. 8(11): p. 2180-2196. 
 
25. Sanjana, N.E., O. Shalem and F. Zhang, Improved vectors and genome-wide 
libraries for CRISPR screening. Nat Meth, 2014. 11(8): p. 783-784. 
 
26. Zhu, S., X. Rong Z Fau - Lu, Y. Lu X Fau - Xu, X. Xu Y Fau - Fu and X. Fu, 
Gene Targeting Through Homologous Recombination in Monkey Embryonic 
Stem Cells Using CRISPR/Cas9 System. (1557-8534 (Electronic)). 
 
27. Lieber, M.R., Y. Ma, U. Pannicke and K. Schwarz, Mechanism and regulation of 
human non-homologous DNA end-joining. Nat Rev Mol Cell Biol, 2003. 4(9): p. 
712-720. 
 
28. Takata, M., M.S. Sasaki, E. Sonoda, C. Morrison, M. Hashimoto, et al., 
Homologous recombination and non-homologous end-joining pathways of DNA 
double-strand break repair have overlapping roles in the maintenance of 
chromosomal integrity in vertebrate cells. The EMBO Journal, 1998. 17(18): p. 
5497-5508. 
 
29. Weterings, E. and D.J. Chen, The endless tale of non-homologous end-joining. 
Cell Res, 2008. 18(1): p. 114-124. 
 
30. Mladenov, E. and G. Iliakis, Induction and repair of DNA double strand breaks: 
The increasing spectrum of non-homologous end joining pathways. Mutation 
Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2011. 
711(1–2): p. 61-72. 
 
31. Stark, J.M., A.J. Pierce, J. Oh, A. Pastink and M. Jasin, Genetic Steps of 
Mammalian Homologous Repair with Distinct Mutagenic Consequences. 
Molecular and Cellular Biology, 2004. 24(21): p. 9305-9316. 
 
32. Burma, S., B.P.C. Chen and D.J. Chen, Role of non-homologous end joining 
(NHEJ) in maintaining genomic integrity. DNA Repair, 2006. 5(9–10): p. 1042-
1048. 
 
33. Zhao, Y., Z. Dai, Y. Liang, M. Yin, K. Ma, et al., Sequence-specific inhibition of 
microRNA via CRISPR/CRISPRi system. Scientific Reports, 2014. 4: p. 3943. 
  28 
34. Jiang, Q., X. Meng, L. Meng, N. Chang, J. Xiong, et al., Small indels induced by 
CRISPR/Cas9 in the 5′ region of microRNA lead to its depletion and Drosha 
processing retardance. RNA Biology, 2014. 11(10): p. 1243-1249. 
 
35. Kuscu, C., S. Arslan, R. Singh, J. Thorpe and M. Adli, Genome-wide analysis 
reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat 
Biotech, 2014. 32(7): p. 677-683. 
 
36. Sakuma, T., A. Nishikawa, S. Kume, K. Chayama and T. Yamamoto, Multiplex 
genome engineering in human cells using all-in-one CRISPR/Cas9 vector system. 
Scientific Reports, 2014. 4: p. 5400. 
 
37. Yaung, S.J., K.M. Esvelt and G.M. Church, CRISPR/Cas9-Mediated Phage 
Resistance Is Not Impeded by the DNA Modifications of Phage T4. PLoS ONE, 
2014. 9(6): p. e98811. 
 
38. Hendel, A., R.O. Bak, J.T. Clark, A.B. Kennedy, D.E. Ryan, et al., Chemically 
modified guide RNAs enhance CRISPR-Cas genome editing in human primary 
cells. Nat Biotech, 2015. 33(9): p. 985-989. 
 
39. Wang, D., H. Mou, S. Li, Y. Li, S. Hough, et al., Adenovirus-Mediated Somatic 
Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-
Specific Immune Responses. (1557-7422 (Electronic)). 
 
40. Kim, S., D. Kim, S.W. Cho, J. Kim and J.-S. Kim, Highly efficient RNA-guided 
genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. 
Genome Research, 2014. 24(6): p. 1012-1019. 
 
41. Maggio, I., M. Holkers, J. Liu, J.M. Janssen, X. Chen, et al., Adenoviral vector 
delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted 
mutagenesis in a diverse array of human cells. Scientific Reports, 2014. 4: p. 
5105. 
 
42. Szilvassy, S.J., T.E. Meyerrose, P.L. Ragland and B. Grimes, Differential homing 
and engraftment properties of hematopoietic progenitor cells from murine bone 
marrow, mobilized peripheral blood, and fetal liver. Blood, 2001. 98(7): p. 2108-
2115. 
 
43. Duran-Struuck, R. and R.C. Dysko, Principles of Bone Marrow Transplantation 
(BMT): Providing Optimal Veterinary and Husbandry Care to Irradiated Mice in 
BMT Studies. Journal of the American Association for Laboratory Animal 
Science : JAALAS, 2009. 48(1): p. 11-22. 
 
  29 
44. Xie, K., B. Minkenberg and Y. Yang, Boosting CRISPR/Cas9 multiplex editing 
capability with the endogenous tRNA-processing system. Proceedings of the 
National Academy of Sciences of the United States of America, 2015. 112(11): 
p. 3570-3575. 
 
45. Guilinger, J.P., D.B. Thompson and D.R. Liu, Fusion of catalytically inactive 
Cas9 to FokI nuclease improves the specificity of genome modification. Nat 
Biotech, 2014. 32(6): p. 577-582. 
 
46. Wang, F., X.-S. Wang, G.-H. Yang, P.-F. Zhai, Z. Xiao, et al., miR-29a and miR-
142-3p downregulation and diagnostic implication in human acute myeloid 
leukemia. Molecular Biology Reports, 2012. 39(3): p. 2713-2722. 
 
47. Zhuang, G., C. Meng, X. Guo, P.S. Cheruku, L. Shi, et al., A Novel Regulator of 
Macrophage Activation: miR-223 in Obesity Associated Adipose Tissue 
Inflammation. Circulation, 2012. 
 
48. Kutner, R.H., X.-Y. Zhang and J. Reiser, Production, concentration and titration 
of pseudotyped HIV-1-based lentiviral vectors. Nat. Protocols, 2009. 4(4): p. 
495-505. 
 
49. Ichim, C.V. and R.A. Wells, Generation of high-titer viral preparations by 
concentration using successive rounds of ultracentrifugation. Journal of 
Translational Medicine, 2011. 9: p. 137-137. 
 
 
